Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Rift Valley Fever Virus can be transmitted from mother to foetus in rats
Foetal death occurred in pups from infected yet asymptomatic dams.
First study to discover vertical transmission in species other than livestock

A study, published on ‘Science Advances’, states that it is the first study to demonstrate fatal vertically transmitted infection with Rift Valley Fever Virus (RVFV) in a species other than livestock.

The research discovered direct placental infection with RVFV as a mechanism for vertical transmission and foetal demise in rats and suggests that the results now emphasise the possible impact of a future epidemic.

A pregnant rodent model was developed in the study in order to investigate how RVFV infection during pregnancy affects the foetus. It was found that infection in dams had a widespread viral distribution with preference for replication and tissue damage in the placenta; identifying direct placental infection as a mechanism for vertical transmission.

The study also found that the mortality rate of RVFV infection was greater in pregnant rats than non-pregnant rats, and that foetal death and significant congenital abnormalities occurred in pups from infected yet asymptomatic dams.

Pregnant women infected with RVFV has been associated with miscarriage. The researchers of this study state that their results suggest that even mild RVFV infection may still have a devastating impact on the developing foetus.

RVFV infection in humans results either from infected mosquitoes, or from contact with contaminated blood or organs with infected animals. To date, there have been known cases of human-to-human transmission of RVFV.    

The full study can be read here.



Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.